"The pinnacle of human health": who are the "superpoopers" and how science could find the perfect feces

rss · BBC Mundo 2026-11-19T19:00:58Z es
Fecal transplants are on the rise, although fewer than 3% of us produce material suitable for donation. And even fewer people are "superdonors" of feces.
Image source, BBC/ Emmanuel LafontAuthor, Sofia QuagliaRole, BBC FuturePublication date, 35 minutesReading time: 11 min In 2013, Adam Faye wondered what kind of dinner would produce the highest-quality stool. At the time, Faye was a fourth-year medical student learning to treat Clostridioides difficile, a bacterial infection that causes serious gastrointestinal problems and is, by nature, resistant to many antibiotics. An elderly patient was suffering from severe and recurrent infections. She needed a fecal microbiota transplant. This pioneering procedure involved introducing stool from another person directly into the patient's colon, thereby incorporating a healthier community of microorganisms into her gut. The goal was for these microorganisms to displace C. difficile and restore balance. But where would the stool come from? At the time, there were not many stool banks, and the patient's family and friends could not or would not donate. So Faye stepped forward. The night before the big day, Faye opted for a burrito for dinner. Skip Most read and continue readingMost readEnd of Most readThe next morning, in his student accommodation, he defecated into a pink medical wedge. Then, he filtered the contents through a cotton gauze with a saline solution and poured it into a bottle. "I remember putting it in a paper bag, because I was walking around with that bottle of cloudy water," he says. A few hours later, Faye's stool was introduced into the patient's intestine during a colonoscopy. Faye, a gastroenterologist and director of clinical research at New York University, later learned that the procedure had worked: the patient never suffered another C. difficile infection. Image source, AFP via Getty ImagesImage caption, By introducing stool from another person directly into a patient's colon, a healthier community of microorganisms is incorporated into their gut. In the years since, research on the role of the gut microbiome in health has skyrocketed. In parallel, interest in stool transplants, technically known as fecal microbiota transplants (FMT), has grown. These transplants are already approved to treat C. difficile infection and are being studied around the world for various conditions, such as irritable bowel, diabetes, autism, and osteoporosis. There is even interest in using them to treat cognitive decline and mental illness. Fecal transplants can be administered directly into the intestine or orally, via capsules containing the stool. However, finding people whose stool is suitable for these purposes is no easy task. The screening process is extremely rigorous, and only the healthiest candidates are considered suitable donors. The best stool — from donors colloquially called "superpoopers" — is even harder to come by. For this report, I contacted six stool banks and laboratories to request interviews with their donors. All agreed that finding reliable donors is so difficult that they cannot risk invading their privacy and causing them to withdraw. So, who are these "elite poopers," and how can science find the perfect stool? The poopers Image source, Getty ImagesImage caption, Finding people whose stool is suitable for these purposes is no easy task. The screening process for a stool donor is not universal; it varies depending on the condition being treated. However, it is an extremely exhaustive procedure. "We look for a person who enjoys optimal human health and subject them to an evaluation process as rigorous as the one applied to an organ donor," explains Carl Crawford, a gastroenterologist and professor at Cornell University in New York. Crawford says the donor is examined exhaustively, as would be done with someone donating a kidney or blood. To become a stool donor, one must first complete several health questionnaires and interviews, as well as undergo detailed blood and stool tests to detect infectious diseases. The list can include more than 30 pathogens, parasites, and multidrug-resistant organisms. Some clinics even require testing for covid-19 and the flu. This is because many infectious diseases can be transmitted through stool. In some cases, FMT has accidentally caused the transmission of E. coli. Some respiratory infections, including covid-19, can be transmitted through fecal particles dispersed in the air when flushing the toilet. Donors' medical histories are also evaluated in relation to certain conditions, such as some autoimmune disorders or mental health problems. Image source, UIG via Getty ImagesImage caption, Stool transplants are approved to treat C. difficile infection and are being studied for conditions such as irritable bowel, diabetes, autism, and osteoporosis. Some laboratories carefully examine the medications and supplements that potential donors consume, including multivitamins and iron. "We look at this carefully and assess whether it is possible for them to stop taking them," says Susan Poutanen, a medical microbiologist at the University of Toronto in Canada. At that center, donors must also indicate whether they have consumed common allergens during the previous week. "Sometimes we need stool free of traces of nuts," explains Poutanen. Donors are generally between 18 and 48 years old; anyone can receive the transplant. "We have treated patients who are 17 years old and also people who are 96," says Susy Hota, an infectious disease specialist at the University of Toronto who performs FMTs. Although most stool donation programs do not explicitly evaluate their donors' diets, ideally they should follow a relatively healthy, fiber-rich diet. Fruits, vegetables, and whole grains typically provide the gut microbiome with the components it needs to thrive. "One might think that donors should be vegetarians, but those who follow an omnivorous diet seem to have greater biodiversity in their gastrointestinal tract," Crawford notes. Whenever possible, donors should also have a slim build, Hota and Poutanen indicate. Image source, Getty ImagesImage caption, Some laboratories carefully examine the medications and supplements that potential donors consume. In one case, a 32-year-old woman who was previously slim developed obesity after receiving a stool donation from a healthy but overweight donor. Many other factors are also taken into account, from alcohol consumption to exercise and sleep. There may even be strict travel restrictions, given the possibility that donors might inadvertently acquire drug-resistant gut bacteria. Although Crawford no longer personally collects stool samples for transplants, he says that, in his experience, about 3% of applicants pass the initial evaluation. Of those, approximately half are considered to have the right bacterial balance to become regular donors. In Hota's case, in Toronto, only about 1.6% of potential donors pass the initial evaluation. And about 0.6% end up being selected as regular donors. Image source, Getty ImagesImage caption, A donor's stool can be encapsulated into pills for oral administration, or introduced directly into a person's intestine via spraying. Regular donation Scientists who run stool banks or research programs indicate, however, that the logistical and practical requirements of being a stool donor should not be underestimated at all. Faye's case — a one-time donation for someone he knew — is not typical. If you are one of the few donors who pass the screening process, you will likely be invited to participate in a regular donation program. The routine involves going to the laboratory almost daily to defecate in a toilet reserved for donors. Many stool banks offer financial compensation to donors. In the United States, compensation can range from US$25 to US$100 per donation. Each stool bank usually has regular donors, as it is more efficient than finding new people each time. "The relationship with donors seems fascinating to me," says Hota. This infectious disease specialist explains that it is necessary to build a relationship of trust while respecting donors' autonomy. For example, they are often asked to report any small change in their lifestyle. Stool preparation To prepare stool samples for a transplant, Elizabeth Hohmann, a researcher and physician at Massachusetts General Hospital in the US, first makes a semi-liquid mixture from them. "Thinking about it is disgusting, I know," she admits. Next, the mixture is filtered through five layers of extremely fine mesh, which she purchases from beer industry suppliers. Then, she separates the fecal material and dissolves it in a saline solution, finally freezing the sample. Studies indicate that the best results are obtained when the sample is administered to the patient fresh. Image source, Getty ImagesImage caption, The routine for stool donors involves going to the laboratory almost daily to defecate. The "superpoopers" These initial tests and analyses can only offer limited predictive capacity. The stool of any eligible donor has the same probability of successfully treating recurrent C. difficile infections. But for certain conditions, research suggests that the stool of some "special" donors leads to significantly higher remission rates compared to others. For example, in a 2015 study evaluating fecal microbiota transplants for ulcerative colitis — a type of bowel disease — only nine of the 38 participants achieved remission. Seven of them had received stool from the same donor. Another study, from 2017, involved combining stool from up to seven different donors for the transplant. Those who received a mixture that included material from a "special" donor were approximately twice as likely to experience improvement compared to those who received a mixture that did not contain it. It is not clear what made this stool — a kind of "cream of the crop" of fecal matter — so effective, and complete microbiome analyses during stool donation are not common practice. Image source, AFP via Getty ImagesImage caption, Anyone can receive a stool transplant, but not anyone can be a donor. However, research has revealed that donors whose stool is especially effective tend to have great abundance and wide diversity of gut bacteria. Their stool also tends to contain species known to be beneficial, such as Faecalibacterium prausnitzii. This species produces butyrate, a fatty acid that performs various useful functions, such as reducing inflammation and protecting the intestinal lining. Even so, stool is not a miracle solution. The ideal donor for treating a C. difficile infection might have no effect on a person suffering from, for example, irritable bowel or depression, Faye emphasizes. "We are still trying to discover what the secret ingredient is," he says. "I am sure that 'super stool donors' exist," Hohmann maintains. According to her, scientists do not yet have reliable tests to identify them; in part, because there is no precise definition of what "super stool" is. Beyond the search for the "perfect stool," a growing body of research suggests that matching patients with compatible stool donors could be a more promising approach. Scientists could classify donors and patients into categories, based on factors such as the diversity of their gut microbiota. From stool to pills Image source, Getty ImagesImage caption, One alternative is to ingest stool capsules. Even with the best possible material, from the most effective "superdonors," fecal microbiota transplants are far from an exact science. "My biggest reservation probably has to do with the unpredictability of fecal microbiota transplants," says Sara Benterkia, of Queen Mary University of London. "An entire microbial community is being transferred, so there are many variables to take into account," she adds. The different donors, the different preparation methods, and the diversity of recipients can lead to very disparate microbial changes. Crawford, for his part, argues that these transplants could serve as a stepping stone toward more standardized treatments. For example, the company Ferring Pharmaceuticals markets REBYOTA, an enema preparation made from stool from donors with a high abundance of beneficial bacteria. On the other hand, Seres Therapeutics makes VOWST, pills containing certain bacterial spores, also obtained from human stool. Both products are approved in the US for the treatment of recurrent C. difficile infection. Image source, Getty ImagesImage caption, Stool transplants could serve as a stepping stone toward more standardized treatments. In fact, Crawford points out that the future of treating C. difficile infection will probably consist of pills containing microbes carefully selected from healthy donors and subsequently cultivated on a large scale in a laboratory. "Microbiome-based therapies have the potential to represent the future of medicine," Crawford estimates. The prospects of harnessing our microbiomes, however, worry Crawford, given the degree to which modern life alters our natural microbiome. For example, ultra-processed foods are known to reduce the diversity of the gut microbiome. "I worry that we may lose the properties of many of the organisms that inhabit our gastrointestinal tract, which could help us fight the next wave of diseases," Crawford says. He compares the healing potential residing in the gut with the abundance of beneficial chemicals — of plant origin — that have been discovered in tropical rainforests. "The microbiome of our gastrointestinal tract is much more extensive and can be just as useful to us; we simply do not give it the value it deserves." * All content in this article is provided for general informational purposes only and should not be considered a substitute for medical advice provided by healthcare professionals. Download the new BBC World Service app. Choose BBC News Mundo and receive news alerts, documentaries, and analysis, all in one place. Important: the new app is not available in the UK or the United States. You can also follow us on YouTube, Instagram, TikTok, Facebook, X, and on our WhatsApp channel. And don't forget to subscribe here to our newsletter to receive a special selection of our best content every Friday.

Translated from es by z-ai/glm-5.3-flash

Highlight